Q2 2026 results were highlighted by 8% revenue growth, which reached €302 million and expanded margins. Adjusted EBITDA increased 280 basis points to 26% High-value solutions accounted for 45% of total revenue and continued to support our performance. 👉🏼bit.ly/4wOtwfl

We have released our Q1 2026 financial results. For the first quarter of 2026, Stevanato Group delivers 7% revenue growth to €273.6 million, driven by high-value solutions. 🔗 ir.stevanatogroup.com/news-e… #StevanatoGroup #Q1 #FinancialResults

We have released our Q4 and full-year 2025 financial results today, reporting end-of-year revenue growth of 7% (+9% at constant currency), with record High-Value Solutions revenue and expanded margins. 🔗 ir.stevanatogroup.com/news-e… #StevanatoGroup #FinancialResults

We have released our Q3 2025 financial results. For the third quarter of 2025, Stevanato Group reports revenue of €303.2 million and record revenue from high-value solutions. 🔗 ir.stevanatogroup.com/news-e… #StevanatoGroup #Q3 #FinancialResults

We have released our Q2 2025 financial results. Explore the key highlights and read the full statement here: Stevanato Group Reports Revenue of €280 Million for the Second Quarter of 2025. 🔗ir.stevanatogroup.com/news-e… #StevanatoGroup #Q2 #FinancialResults

Today we announced new financing agreements totaling €200 million with @BNLBNPParibas_, @GruppoCDP, and @BancoBPMSpa. The funds will support capacity expansion in Italy and the U.S. 🔗 Learn more: ir.stevanatogroup.com/news-e…

We have released our Q1 2025 financial results. Explore the key highlights and read the full statement here: Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025. 👉 shorturl.at/mJbuL #StevanatoGroup #Q1 #FinancialResults

We have released our Q4 and year-end 2024 financial results. Explore the key highlights and read the full statement here: ir.stevanatogroup.com/news-e… #StevanatoGroup #FinancialResults #ManagingComplexityDeliveringValue

We have released our Q3 financial results. Read the highlights and our full statement here: ir.stevanatogroup.com/news-e….. #StevanatoGroup #Q3 #FinancialResults #ManagingComplexityDeliveringValue

Stevanato Group will introduce Vertiva® 10mL On-Body Delivery System for injectable therapies at @CPHI_Events Milan. Delve into its features and find all the details about our launch in the press release: stevanatogroup.com/en/news-e… #StevanatoGroup #Vertiva #OBDS

Great news! We are joining forces with @Gerresheimer and #SCHOTTPharma and announcing our strategic “Alliance for RTU”! Curious to know more? Visit us at CPHI Milan or read the full press release: ir.stevanatogroup.com/news-e… #StevanatoGroup #RTUAlliance

We have just released our Q2 financial results. Find all the key figures and our full statement here: ir.stevanatogroup.com/news-e… #StevanatoGroup #FinancialResults #ManagingComplexityDeliveringValue

Information and prevention are key to ensuring the safety and well-being of workers. And at Stevanato Group we care, that's why last month was rich in Health, Safety and Environment activities! ✨ Our colleagues in Monterrey, Mexico, organized four educational and informative sessions, to discuss ergonomics, unsafe behaviors, and glass scrap recycling. ✨ Similarly, our staff in Fishers, U.S., held six lessons about climate change and its impact on occupational health and safety, followed by a talk on safe behaviors delivered by the Local Fire Department. These initiatives represent an important opportunity to reflect on our HSE accomplishments and future projects while reaffirming our commitment to promote the highest standards in all our sites, worldwide! #StevanatoGroup #HSE #HSEWeek #IntegratedSolutionsProvider #MakeItHappen

Are you looking for a state-of-the-art cartridge designed to perfectly match your drug delivery device’s needs? Our wide range of Nexa® EZ-fill® solutions is optimal to increase flexibility while reducing your time to market and TCO, thanks to its key attributes: 🌟 Ready-to-use: pre-washed, pre-siliconized, pre-crimped/un-capped, pre-sterilized 🌟 Widest range of formats and choice of rubber components 🌟 Nest and tray configurations, aligned with ISO 21881 and ISO 11040-7 🌟 Optimized baked-on siliconization 🌟 High mechanical resistance and high cosmetic quality Discover more: stevanatogroup.com/en/offeri… #StevanatoGroup #Nexa #IntegratedSolutionsProvider #YourPartnerOfChoice

The current EU GMP Annex 1 emphasizes the importance of handling critical manufacturing steps and managing risks associated with contamination. It is crucial for pharmaceutical companies to align their quality management system and establish appropriate CCS Contamination Control Strategy (CCS) and Quality Risk Management (QRM). At Stevanato Group, we can help you meet these requirements reducing the risk in your operations throughout the process. How? With our EZ-fill® platform, a fully integrated pre-washed and pre-sterilized containment solution for your aseptic manufacturing. By choosing Ready-To-Use (RTU) containers, you can significantly automate your manufacturing process and reduce human intervention, minimizing potential risks of contamination connected to the washing and depyrogenation phases, making your operations leaner, and allowing you to focus on key activities with the most added value. Take advantage of: ✔️ Reduced contamination sources ✔️ Simplified CCS implementation ✔️ Preserved container quality for patients' safety Discover how RTU containers can be a smart solution to aseptic manufacturing challenges: stevanatogroup.com/en/news-e… #StevanatoGroup #IntegratedSolutionsProvider #EZfill #RTUContainers

⏩ @CPHI_Events China is a little more than a month away, and we can’t wait to meet you in Shanghai. Join us in exploring our cutting-edge drug containment solutions and how our technologies and equipment can optimize your production – and don’t miss our speech about “Innovative solutions in primary packaging for biologics applications” on June 20th at 3:20 pm! Book a meeting with our team to discuss how we can become your one-stop-shop partner: stevanatogroup.com/en/meetin… #StevanatoGroup #CPHIChina #IntegratedSolutionsProvider #MakeItHappen

🧪 The growth of biologics and GLP-1 is driving the need for new solutions both in terms of primary containers and drug delivery devices. Thanks to our integrated capabilities, we can support our customers in selecting the right solution according to their specific needs: ✅ #Alba® syringes, our breakthrough solution for silicone-related challenges, achieving near-zero levels of particles and optimizing drug-container compatibility. ✅ #Nexa® syringes, designed for seamless integration into auto-injection devices, showing ultra-low tungsten and glue residuals, alongside high cosmetic quality. ✅ #Aidaptus® two-step, single-use auto-injector, ideally suited to our breakthrough Alba® and Nexa® pre-fillable syringes, offering tailored solutions to unique technological needs. Discover more about our unique approach as a one-stop-shop provider, on Drug Development & Delivery: drug-dev.com/wp-content/uplo… #StevanatoGroup #IntegratedSolutionsProvider

⏩ Join us on this incredible journey through the progression of our new Cisterna di Latina, Italy, manufacturing site! With this new high-tech hub, we take another step forward in better serving the growing biotech market, through our high-value drug containment solutions - EZ-fill® Syringes and Cartridges. Enjoy this sneak peek of its evolution, from the installation of the first lines to the start of the commercial production! 👇 #StevanatoGroup #IntegratedSolutionsProvider #Expansion #YourPartnerOfChoice

Continuous evaluation of drug-device combination products is crucial from development through launch, as each device may react differently to your drug product. Our Technology Excellence Centers support the many phases of your Validation Master Plan, as early as determining components to be tested, methods to be used and ultimately executing your Design Verification Testing (DVT). 👉 Find out more on how our test-driven approach helps you select the optimal product and get to the market with less risk in our latest white paper by our colleague Alan Xu: stevanatogroup.com/en/evt-dv… #EVT #DVT #IntegratedSolutionsProvider #TechnologyExcellenceCenters #StevanatoGroup

📅 SAVE THE DATE: from 15 to 16 May we are attending the 2024 PDA Good Aseptic Manufacturing Conference, in Germany! Our Corporate Regulatory and Scientific Affairs Manager Andrea Salmaso will take part in the conference as a Committee Member, as well as the moderator of the “Impact of EU GMP Annex 1 on Lyophilization” session, from 02.00 pm to 03.20 pm on the first day of the event. Register now to secure your spot: stevanatogroup.com/en/news-e… @PDAonline #StevanatoGroup #PDA #IntegratedSolutionsProvider #MakeItHappen